Bone Biologics Corp
News
Bone Biologics Corporation to Present at the H.C. Wainwright 26th Annual Global Investment Conference
Business Wire Bone Biologics Corporation (Bone Biologics or the Company) (Nasdaq: BBLG, BBLGW), a developer of orthobiologic products for spine fusion markets, announces that Jeffrey Frelick, chief executive...\n more…
Bone Biologics Co. (NASDAQ:BBLG) Short Interest Update
Ticker Report Bone Biologics Co. (NASDAQ:BBLG - Get Free Report) was the target of a significant drop in short interest during the month of August. As of August 15th, there was short interest totalling 18,200...\n more…
Equities Analysts Set Expectations for Bone Biologics Co.'s Q3 2024 Earnings (NASDAQ:BBLG)
Ticker Report Bone Biologics Co. (NASDAQ:BBLG - Free Report) - Investment analysts at Zacks Small Cap raised their Q3 2024 earnings per share estimates for Bone Biologics in a report issued on Monday, August 12th...\n more…
Bone Biologics Co. (NASDAQ:BBLG) Short Interest Update
Ticker Report Bone Biologics Co. (NASDAQ:BBLG - Get Free Report) saw a significant increase in short interest in July. As of July 31st, there was short interest totalling 172,900 shares, an increase of 3,162.3...\n more…
Bone Biologics files to sell 1.62M shares of common stock for holders
SeekingAlpha.com: All News Explore the latest filing of a prospectus in the financial sector.\n more…